Sign in

CIK 0001711279 · Large accelerated filer

Krystal Biotech, Inc.

Sign in to watch
Ticker
KRYS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
821080209
Phone
(412) 586-5830
Business address
2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, 15203
  1. 144 Insider Sale of Securities
  2. 8-K Event Results of operations
  3. S-8 Other Securities Offered to Employees in Benefit Plans
  4. 10-K Report Annual Report
  5. SC 13G/A Stake Amended Statement of Ownership
  6. SC 13G/A Stake Amended Statement of Ownership
  7. SC 13G Stake Amended Statement of Ownership
  8. SC 13G/A Stake Amended Statement of Ownership
  9. SC 13G/A Stake Amended Statement of Ownership
  10. SC 13G/A Stake Amended Statement of Ownership
  11. 4 Planned sale Chief Accounting Officer sold 2,500 shares at $130.00 ($325,000)
  12. 144 Insider Sale of Securities
  13. 4 Planned sale President, R&D sold 50,000 shares at an average $105.67 ($5,283,291)
  14. 4 Planned sale President and CEO sold 50,000 shares at an average $105.67 ($5,283,291)
  15. 144 Insider Sale of Securities
  16. 144 Insider Sale of Securities
  17. 8-K Event Results of operations
  18. 10-Q Report Quarterly Report
  19. 144 Insider Sale of Securities
  20. 4 Planned sale President, R&D sold 50,000 shares at an average $127.23 ($6,361,680)

Page 9 of 26 · 513 filings